Literature DB >> 19157245

Objectively measured physical activity and cardiovascular disease risk factors in African American girls.

Sofiya Alhassan1, Thomas N Robinson.   

Abstract

OBJECTIVE: This study examines the associations between objectively measured physical activity and cardiovascular disease (CVD) risk factors in preadolescent African American girls.
METHODS: We conducted a cross-sectional analysis of data from Stanford Girls Health Enrichment Multisite Studies (GEMS) trial. Physical activity was assessed for four days by using an ActiGraph accelerometer and was correlated with anthropometric measures, blood pressure, blood lipids, glucose, and insulin. Associations between physical activity and CVD risk factors were computed using by Spearman correlations. Bonferroni adjustment alpha = .003 was used to correct for multiple testing.
RESULTS: A total of 261 girls participated, of which 208 had complete CVD risk measures (mean age 9.4 years, mean body mass index 20.7 kg/m2). Average daily physical activity and time spent in moderate-to-vigorous physical activity (MVPA) were significantly correlated with body mass index (r = -.23, P=.0008 and r = -.29, P<.0001, respectively) and insulin (r = -.27, P=.0001 and r = -.30, P<.0001, respectively) but not to other CVD factors. After adjusting for age-adjusted pubertal stage of development, the association between MVPA and insulin remained significant.
CONCLUSIONS: Objective measures of both average daily physical activity and MVPA were inversely associated with body mass index and insulin levels in African American girls.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19157245      PMCID: PMC3863587     

Source DB:  PubMed          Journal:  Ethn Dis        ISSN: 1049-510X            Impact factor:   1.847


  25 in total

1.  Adolescent physical activity and inactivity vary by ethnicity: The National Longitudinal Study of Adolescent Health.

Authors:  P Gordon-Larsen; R G McMurray; B M Popkin
Journal:  J Pediatr       Date:  1999-09       Impact factor: 4.406

Review 2.  A review of correlates of physical activity of children and adolescents.

Authors:  J F Sallis; J J Prochaska; W C Taylor
Journal:  Med Sci Sports Exerc       Date:  2000-05       Impact factor: 5.411

3.  The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents.

Authors: 
Journal:  Pediatrics       Date:  2004-08       Impact factor: 7.124

4.  Defining accelerometer thresholds for activity intensities in adolescent girls.

Authors:  Margarita S Treuth; Kathryn Schmitz; Diane J Catellier; Robert G McMurray; David M Murray; M Joao Almeida; Scott Going; James E Norman; Russell Pate
Journal:  Med Sci Sports Exerc       Date:  2004-07       Impact factor: 5.411

5.  National Cholesterol Education Program (NCEP): highlights of the report of the Expert Panel on Blood Cholesterol Levels in Children and Adolescents.

Authors: 
Journal:  Pediatrics       Date:  1992-03       Impact factor: 7.124

6.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

Authors:  W T Friedewald; R I Levy; D S Fredrickson
Journal:  Clin Chem       Date:  1972-06       Impact factor: 8.327

7.  Serum lipids, glucose and insulin levels in healthy schoolchildren aged 9 and 15 years from Central Sweden: reference values in relation to biological, social and lifestyle factors.

Authors:  A H Wennlöf; A Yngve; T K Nilsson; M Sjöström
Journal:  Scand J Clin Lab Invest       Date:  2005       Impact factor: 1.713

8.  Assessing weight-related biochemical cardiovascular risk factors in African-American girls.

Authors:  Darrell M Wilson; Yun Wang; Karen W Cullen; Tom Baranowski; John H Himes; Myron Gross; Barbara S McClanahan; Thomas N Robinson
Journal:  Obes Res       Date:  2004-09

9.  Estimated daily energy expenditure and blood lipids in adolescents: the Québec Family Study.

Authors:  Joey C Eisenmann; Peter T Katzmarzyk; Louis Perusse; Claude Bouchard; Robert M Malina
Journal:  J Adolesc Health       Date:  2003-09       Impact factor: 5.012

10.  Physical activity and clustered cardiovascular risk in children: a cross-sectional study (The European Youth Heart Study).

Authors:  Lars Bo Andersen; Maarike Harro; Luis B Sardinha; Karsten Froberg; Ulf Ekelund; Søren Brage; Sigmund Alfred Anderssen
Journal:  Lancet       Date:  2006-07-22       Impact factor: 79.321

View more
  5 in total

1.  Accelerometer use in a physical activity intervention trial.

Authors:  Melissa A Napolitano; Kelley E Borradaile; Beth A Lewis; Jessica A Whiteley; Jaime L Longval; Alfred F Parisi; Anna E Albrecht; Christopher N Sciamanna; John M Jakicic; George D Papandonatos; Bess H Marcus
Journal:  Contemp Clin Trials       Date:  2010-08-17       Impact factor: 2.226

Review 2.  Accelerometer use with children, older adults, and adults with functional limitations.

Authors:  Scott J Strath; Karin A Pfeiffer; Melicia C Whitt-Glover
Journal:  Med Sci Sports Exerc       Date:  2012-01       Impact factor: 5.411

3.  Associations of Vigorous-Intensity Physical Activity with Biomarkers in Youth.

Authors:  Justin B Moore; Michael W Beets; Keith Brazendale; Steven N Blair; Russell R Pate; Lars B Andersen; Sigmund A Anderssen; Anders Grøntved; Pedro C Hallal; Katarzyna Kordas; Susi Kriemler; John J Reilly; Luis B Sardinha
Journal:  Med Sci Sports Exerc       Date:  2017-07       Impact factor: 5.411

4.  Effect of a culturally-tailored mother-daughter physical activity intervention on pre-adolescent African-American girls' physical activity levels.

Authors:  Sofiya Alhassan; Ogechi Nwaokelemeh; Cory J Greever; Sarah Burkart; Matthew Ahmadi; Christine W St Laurent; Daheia J Barr-Anderson
Journal:  Prev Med Rep       Date:  2018-05-09

Review 5.  Cardiovascular disease risk in healthy children and its association with body mass index: systematic review and meta-analysis.

Authors:  Claire Friedemann; Carl Heneghan; Kamal Mahtani; Matthew Thompson; Rafael Perera; Alison M Ward
Journal:  BMJ       Date:  2012-09-25
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.